ASC and caspase-1 were found to be elevated in the serum of MS patients compared to the control group. IL-1β was found to be decreased. ASC levels were higher in MS patients with moderate disease onset compared to the mild group. This evidence concerns the gene PYCARD and myeloid sarcoma.